XJPX
3649
Market cap140mUSD
Feb 24, Last price
811.00JPY
1D
-8.67%
1Q
-18.33%
Jan 2017
-14.45%
IPO
873.24%
Name
Findex Inc
Chart & Performance
P/E
17.03
P/S
3.39
EPS
47.62
Div Yield, %
1.91%
Shrs. gr., 5y
0.05%
Rev. gr., 5y
6.41%
Revenues
5.84b
+12.51%
Net income
1.16b
+9.75%
CFO
1.90b
+125.28%
Dividend
Jun 29, 202613 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||